Live Breaking News & Updates on China Medical System Holdings Limited

Stay updated with breaking news from China medical system holdings limited. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

China Medical System (00867) Obtained Exclusive License of a First-line Phosphate-lowering Drug Velphoro(R) – IT Business Net

China Medical System (00867) Obtained Exclusive License of a First-line Phosphate-lowering Drug Velphoro(R) – IT Business Net
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Shenzhen , Guangdong , China , Macao , Macau-general , Macau , Taiwan , Chinese , Urol-nephrol , Clin-nephrol , Meixiang-chen , National-medical-products-administration


acnnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from acnnewswire.com Daily Mail and Mail on Sunday newspapers.

Tuas , Singapore-general , Singapore , Shenzhen , Guangdong , China , Australia , Chinese , Contract-development , Therapeutic-goods-administration-of-australia , Rxilient-health-pte

China Medical System: 4 Products Have Been Newly Included or Continued to be Included in the NRDL – IT Business Net

China Medical System: 4 Products Have Been Newly Included or Continued to be Included in the NRDL – IT Business Net
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Tibet , Xizang , China , Shanghai , Shenzhen , Guangdong , Singapore , Taiwan , Macau , Hong-kong , Republic-of-china , Taiwan-general

Sun Pharma specialty drug Tildrakizumab makes it to China's reimbursement list

The inclusion of tildrakizumab injection in NRDL will further boost Sun Pharma commercialisation efforts globally. NRDL is a list of drugs fully or partially reimbursed by the national basic health insurance in China covering 96% of the population or more than 1.36 billion people. ....

Mumbai , Maharashtra , India , China , Sun-pharma , National-medical-products-administration , China-medical-system-holdings-limited , China-national-reimbursement-drug-list , National-reimbursement-drug-list , Tildrakizumab , Specialty-drug , China-reimbursement-list